Information about the link integrated into the post
Clinical trial
Hoffmann-La Roche (2018). A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension. ClinicalTrials.gov. Hoffmann-La Roche.
More information